Qianhai Health Holdings Full Year 2024 Earnings: EPS: HK$0.008 (vs HK$0.31 loss in FY 2023)

Simply Wall St.03-27
Advertisement

Qianhai Health Holdings (HKG:911) Full Year 2024 Results

Key Financial Results

  • Revenue: HK$519.7m (down 46% from FY 2023).
  • Net income: HK$1.31m (up from HK$52.7m loss in FY 2023).
  • Profit margin: 0.3% (up from net loss in FY 2023).
  • EPS: HK$0.008 (up from HK$0.31 loss in FY 2023).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

SEHK:911 Earnings and Revenue History March 27th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Qianhai Health Holdings shares are down 3.6% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 2 warning signs for Qianhai Health Holdings (1 shouldn't be ignored!) that you need to be mindful of.

Valuation is complex, but we're here to simplify it.

Discover if Qianhai Health Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment